Trial Profile

A Single Arm, Single Dose Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Select Organs in Patients With Systemic Amyloidosis

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 19 Sep 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs AT-03 (Primary)
Indications Amyloid light-chain amyloidosis; Amyloidosis
Focus Pharmacokinetics
Acronyms AT03-001
Sponsors Attralus

Most Recent Events

14 Sep 2022 Status changed from active, no longer recruiting to completed.
12 Sep 2022 Planned End Date changed from 30 Aug 2022 to 30 Nov 2022.
12 Sep 2022 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com